Diagnostics and Tools January 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Sofie Biosciences, Inc. (25.8% stake) was acquired by Trilantic Capital Management L.P.
• Roche Diagnostics Corporation announced its acquisition of LumiraDx Point-of-Care Testing Tech
• Elephas Biosciences Corporation closed a $55MM Series A Financing, led by Arch Venture Partners, L.P., State of Wisconsin Investment Board, Venture Investors, LLC, Sands Capital Management, LLC, Tao Capital Partners, Northpond Ventures, LLC, dRx Capital AG, WARF Ventures